Prostate Cancer Screening Is Broken – How Do We Fix It?

PSA testing can reduce mortality but has limitations.

Overdiagnosis is a major issue in PSA screening.

IsoPSA can significantly reduce unnecessary biopsies.

Age and family history affect PSA interpretation.

Guidelines recommend age-adjusted PSA thresholds.

MRI and biomarker tests improve risk assessment for biopsies.

Open discussions with patients about guidelines are essential.

Future diagnostics may integrate AI with multiple data sources.